20 LATEST RESOURCES (8 INDEXED)
×
Pimavanserin (Nuplazid): A Treatment for Hallucinations and Delusions Associated with Parkinson’s Disease · June 2017
Articles
NCBI>Pharmacy and Therapeutics
×
Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder · July 2016
Articles
NCBI>Pharmacy and Therapeutics
×
Do SSRI Antidepressants Increase the Risk of Extrapyramidal Side Effects in Patients Taking Antipsychotics? · February 2016
Articles
NCBI>Pharmacy and Therapeutics
×
Vortioxetine (Brintellix): A New Serotonergic Antidepressant · January 2015
Articles
NCBI>Pharmacy and Therapeutics
×
Loxapine Inhalation Powder (Adasuve): A New and Innovative Formulation of an Antipsychotic Treatment for Agitation · September 2014
Articles
NCBI>Pharmacy and Therapeutics
×
Pharmacotherapy for Post-Traumatic Stress Disorder in Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic Agents · January 2012
Articles
NCBI>Pharmacy and Therapeutics
×
Vilazodone HCl (Viibryd): A Serotonin Partial Agonist and Reuptake Inhibitor for the Treatment of Major Depressive Disorder · January 2012
Articles
NCBI>Pharmacy and Therapeutics
×
Safety and Efficacy of Red Yeast Rice (Monascus Purpureus) as an Alternative Therapy for Hyperlipidemia · June 2009
Articles
NCBI>Pharmacy and Therapeutics